ClinicalTrials.gov
public full text
Public Domain
DAS181 for Severe COVID-19: Compassionate Use
The objective of the study is to investigate the safety and potential efficacy of DAS181 for the treatment of severe COVID-19.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)#890033
- COVID-19: Salvage TOcilizumab as a Rescue Measure#1088289
- Tocilizumab for Severe COVID-19 Infection and Multisystem Inflammatory Syndrome in Adults and Children#453441
- Efficacy of Argon-Helium Cryoablation Plus PD-1 Inhibitors in NSCLC#813571
- Study of TB006 in Outpatient Patients With Mild to Moderate COVID-19#839112
Record · ID 1056989
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive